Cocrystal Pharma
COCP
26 hedge funds and large institutions have $784K invested in Cocrystal Pharma in 2026 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 4 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 4
4% more capital invested
Capital invested by funds: $754K → $784K (+$29.4K)
0.04% more ownership
Funds ownership: 5.59% → 5.63% (+0.04%)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
7% less funds holding
Funds holding: 28 → 26 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$21.6K |
| 2 |
VF
Virtu Financial
New York
|
+$13.5K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$7.98K |
| 4 |
Wells Fargo
San Francisco,
California
|
+$6.45K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$2.96K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DS
DRW Securities
Chicago,
Illinois
|
-$32.9K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$8.89K |
| 3 |
FFO
Fortitude Family Office
Scottsdale,
Arizona
|
-$3.15K |
| 4 |
Renaissance Technologies
New York
|
-$2.17K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$877 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
DS
26
DRW Securities
Chicago,
Illinois
| – | -$32.9K | -33,593 | Closed |
|
|
27
Bank of America
Charlotte,
North Carolina
| – | -$8.89K | -9,083 | Closed |
|
|
FFO
28
Fortitude Family Office
Scottsdale,
Arizona
| – | -$3.15K | -3,219 | Closed |
|
|
RFP
29
Root Financial Partners
Encinitas,
California
| – | -$7 | -7 | Closed |
|
COCP Hedge Fund Activity: Q1 2026 in Review
26 of the 8,128 institutional investors tracked by Wall St. Rank reported a position in Cocrystal Pharma (COCP) for Q1 2026, worth a combined $784K — up 3.9% from $754K a quarter earlier.
Fund positioning in COCP was balanced in Q1 2026: 4 funds opened new positions, 4 closed out, 6 added to existing stakes and 4 trimmed.
The largest buyer was XTX Topco, adding an estimated $21.6K. The largest seller was DRW Securities, exiting entirely with an estimated $32.9K sold.
- 26 institutional investors held Cocrystal Pharma (COCP) as of Q1 2026, down from 28 in Q4 2025.
- Funds reported $784K of Cocrystal Pharma stock for Q1 2026, up 3.9% quarter-over-quarter.
- 4 funds opened new Cocrystal Pharma positions in Q1 2026 and 4 closed out, a net change of 0 holders.
- The largest Cocrystal Pharma buyer in Q1 2026 was XTX Topco, an estimated $21.6K added.
- The largest Cocrystal Pharma seller in Q1 2026 was DRW Securities, an estimated $32.9K sold.
Based on aggregated 13F filings for Q1 2026.